FISH for N-myc Oncogene Amplification - Price, Normal Range | Sprint Diagnostics Hyderabad

Patient Preparing : No special preparation is needed for this test.

₹ 8900

Fluorescence in situ hybridization (FISH) for N-myc oncogene amplification is a molecular diagnostic test employed to detect the amplification of the N-myc oncogene in cells. The N-myc oncogene is a gene that can contribute to the transformation of a cell into a cancer cell when it is over-expressed or amplified. Amplification of the N-myc oncogene is associated with several types of cancer, most notably neuroblastoma.

The N-myc oncogene belongs to the Myc family of genes, which are known to be involved in the regulation of cell proliferation, differentiation, and apoptosis. Amplification of N-myc is an abnormality in which there are multiple copies of the gene. This is often associated with an aggressive tumor phenotype, and has been shown to have prognostic significance especially in neuroblastoma.

Test Name FISH for N-myc Oncogene Amplification
Sample Type Paraffin embedded tissue blocks
Preparations Required No special preparation is needed for this test.
Report Time 7days
Price in Hyderabad ₹ 8900

Neuroblastoma is a cancer that develops from immature nerve cells and most commonly affects children. The amplification of the N-myc oncogene is found in approximately 20-25% of neuroblastoma cases and is associated with advanced-stage disease, rapid tumor progression, and poor prognosis.

In the FISH test for N-myc amplification, a sample of blood, bone marrow, or tissue is obtained from the patient. This sample is then fixed on slides, and the DNA is denatured so that it can hybridize with fluorescently labeled probes that are specific to the N-myc gene.

The probes will bind to the regions of the DNA where the N-myc gene is located. Under a fluorescence microscope, the bound probes can be seen as fluorescent signals. In normal cells, there are generally two signals representing the two copies of the N-myc gene. However, in cells with N-myc amplification, multiple signals are seen due to the additional copies of the gene.

The amplification of the N-myc oncogene is considered a high-risk factor in neuroblastoma. Patients with this genetic alteration often have a more aggressive form of the disease, which is more difficult to treat. The presence of N-myc amplification can influence treatment decisions, as high-risk patients may require more aggressive therapy.

Besides neuroblastoma, N-myc amplification has also been observed in other malignancies, such as small cell lung cancer, retinoblastoma, and some brain tumors, although less frequently.

Treatment for cancers with N-myc amplification varies depending on the type and stage of the cancer. For neuroblastoma, a multimodal approach is often used, including chemotherapy, surgery, radiation therapy, stem cell transplant, and targeted therapies.

There is ongoing research on targeted therapies that specifically inhibit the N-myc oncogene. These therapies aim to block the action of the N-myc protein and thus reduce the proliferation of cancer cells.

Home Sample Collection

Confirm Your Slot
Book your convenient slot
Agent Visits To Your Home
Sample Collection by Phlebotomist
Testing Done At Lab
Reporting of the sample at lab
Download Report
Download Reports

HOMA Index Insulin Resistance Test

Popular Tests

Complete Blood Count (CBC)
Complete Blood Count
Know More
Vitamin B12
Vitamin B12
Know More
Liver Function Test (LFT)
Liver Function Test (LFT)
Know More
Glucose Tolerance Test - Extended
Glucose Tolerance Test - Extended
Know More

What does a positive result for N-myc amplification mean?

A positive result indicates that there are multiple copies of the N-myc gene in the cells, which is associated with a higher risk and a more aggressive form of cancer.

Is N-myc amplification inherited?

N-myc amplification is usually not inherited but is acquired during the person's lifetime. It occurs in tumor cells and is associated with the development of cancer.

Can N-myc amplification be detected in a blood test?

FISH for N-myc amplification can be performed on blood or bone marrow samples in some cases. However, tissue samples are often used for solid tumors like neuroblastoma.

What treatments are available for cancers with N-myc amplification?

Treatment options include surgery, radiation therapy, chemotherapy, stem cell transplantation, and experimental targeted therapies.

Is there a cure for cancers with N-myc amplification?

The likelihood of cure varies depending on the type and stage of cancer. Some patients may achieve remission, while others may have a more aggressive disease course.

Can adults have cancers with N-myc amplification?

Yes, while N-myc amplification is most commonly associated with neuroblastoma in children, it can also be seen in cancers that affect adults, such as small cell lung cancer.

How does N-myc amplification affect prognosis?

N-myc amplification is generally associated with a poorer prognosis, particularly in neuroblastoma, due to its association with advanced disease and rapid progression.

FISH for N-myc oncogene amplification is a diagnostic test crucial in the management of several cancers, particularly neuroblastoma. It provides vital information about the genetic makeup of the tumor, which can influence treatment decisions. This test is particularly important in pediatrics, where neuroblastoma is a significant cause of cancer in children. Further research into targeted therapies for tumors with N-myc amplification is ongoing and holds promise for improving outcomes for patients with these high-risk tumors. As always, it is essential for patients and caregivers to communicate with healthcare professionals for the most appropriate advice and information regarding the diagnosis and management of cancers associated with N-myc amplification.

Book Your Slot

Our Locations Near You in Hyderabad
4KM from Madhapur
3KM from Banjara Hills
1.9KM from Yusufguda
3KM from Madhura Nagar
5KM from Shaikpet
Live Chat